Literature DB >> 8958225

Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3.

M Harrela1, H Koistinen, J Kaprio, M Lehtovirta, J Tuomilehto, J Eriksson, L Toivanen, M Koskenvuo, P Leinonen, R Koistinen, M Seppälä.   

Abstract

We assessed the magnitude of the genetic component in the variation of circulating levels of insulin-like growth factors I and II (IGF-I and IGF-II), and their binding proteins IGFBP-1 and IGFBP-3 by measuring their serum concentrations in 32 monozygotic and 47 dizygotic adult twin pairs of the same sex. The intrapair correlation for the IGF-I levels was r = 0.41 (P < 0.009) for monozygotic twins and r = 0.12 (P < 0.22) for dizygotic twins. For the IGF-II concentration the intrapair correlations were r = 0.66 (P < 0.0001) for the monozygotic and r = 0.34 (P < 0.01) for the dizygotic twins. No significant intrapair correlation was found for IGFBP-1 levels in either group. The correlations for IGFBP-3 concentration were r = 0.65 (P < 0.0001) and r = 0.23 (P < 0.06) for monozygotic and dizygotic twins, respectively. Women had higher IGF-II levels than men (635+/-175 vs. 522+/-144 microg/liter; P < 0.0001) and IGFBP-3 levels were also higher in women compared with men (5441+/-1018 vs. 4496+/-1084 microg/liter; P < 0.001). The proportion of variance attributable to genetic effects was 38% for the IGF-I concentration, 66% for the IGF-II concentration, and 60% for the IGFBP-3 concentration. No significant heritability was found for the IGFBP-1 concentrations. Our results show that, in adults, there is a substantial genetic contribution responsible for interindividual variation of the circulating levels of IGF-I, IGF-II, and IGFBP-3, but not for the IGFBP-1 levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958225      PMCID: PMC507720          DOI: 10.1172/JCI119081

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

Review 1.  Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.

Authors:  W H Daughaday; P Rotwein
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

2.  Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein.

Authors:  A M Suikkari; V A Koivisto; E M Rutanen; H Yki-Järvinen; S L Karonen; M Seppälä
Journal:  J Clin Endocrinol Metab       Date:  1988-02       Impact factor: 5.958

3.  The gene encoding human low-molecular weight insulin-like growth-factor binding protein (IGF-BP25): regional localization to 7p12-p13 and description of a DNA polymorphism.

Authors:  T Alitalo; K Kontula; R Koistinen; K Aalto-Setälä; M Julkunen; O A Jänne; M Seppälä; A de la Chapelle
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

4.  The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedures, and research program.

Authors:  J Kaprio; S Sarna; M Koskenvuo; I Rantasalo
Journal:  Prog Clin Biol Res       Date:  1978

5.  Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels.

Authors:  H Koistinen; R Koistinen; L Selenius; Q Ylikorkala; M Seppälä
Journal:  J Appl Physiol (1985)       Date:  1996-03

6.  Somatomedin levels in childhood, adolescence and adult life.

Authors:  K Hall; V R Sara
Journal:  Clin Endocrinol Metab       Date:  1984-03

7.  Organization of the human genes for insulin-like growth factors I and II.

Authors:  P de Pagter-Holthuizen; F M van Schaik; G M Verduijn; G J van Ommen; B N Bouma; M Jansen; J S Sussenbach
Journal:  FEBS Lett       Date:  1986-01-20       Impact factor: 4.124

8.  Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy.

Authors:  R L Hintz; F Liu; R G Rosenfeld; S F Kemp
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

9.  The serum half-life of somatomedin activity: evidence for growth hormone dependence.

Authors:  K L Cohen; S P Nissley
Journal:  Acta Endocrinol (Copenh)       Date:  1976-10

10.  Isolation of the human insulin-like growth factor I gene using a single synthetic DNA probe.

Authors:  A Ullrich; C H Berman; T J Dull; A Gray; J M Lee
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

View more
  69 in total

1.  Problems with GH doping in sports.

Authors:  M Bidlingmaier; Z Wu; C J Strasburger
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 2.  Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer.

Authors:  Robert G Maki
Journal:  J Clin Oncol       Date:  2010-10-25       Impact factor: 44.544

3.  Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.

Authors:  Monica McGrath; I-Min Lee; Julie Buring; Immaculata De Vivo
Journal:  Gynecol Oncol       Date:  2011-02       Impact factor: 5.482

4.  When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?

Authors:  Noriko N Yokoyama; Andria Denmon; Edward M Uchio; Mark Jordan; Dan Mercola; Xiaolin Zi
Journal:  Curr Pharmacol Rep       Date:  2015-04-14

5.  Hormones and the heart: Does the cardiovascular system need growth hormone in adult life?

Authors:  Th B Twickler; M J M Cramer; P J Senden; W R de Vries; H P F Koppeschaar
Journal:  Neth Heart J       Date:  2003-04       Impact factor: 2.380

6.  Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults.

Authors:  David Berrigan; Nancy Potischman; Kevin W Dodd; Stephen D Hursting; Jackie Lavigne; J Carl Barrett; Rachel Ballard-Barbash
Journal:  Growth Horm IGF Res       Date:  2008-09-21       Impact factor: 2.372

7.  Insulin-like growth factor-I and cancer mortality in older men.

Authors:  Jacqueline M Major; Gail A Laughlin; Donna Kritz-Silverstein; Deborah L Wingard; Elizabeth Barrett-Connor
Journal:  J Clin Endocrinol Metab       Date:  2010-01-15       Impact factor: 5.958

8.  The impact of IGF-I gene polymorphisms on coronary artery disease susceptibility.

Authors:  Hsiu-Ling Lin; Kwo-Chang Ueng; Hsiang-Ling Wang; Tsung-Po Chen; Shun-Fa Yang; Shu-Chen Chu; Yih-Shou Hsieh
Journal:  J Clin Lab Anal       Date:  2013-02-19       Impact factor: 2.352

9.  Mapping quantitative trait loci that influence serum insulin-like growth factor binding protein-5 levels in F2 mice (MRL/MpJ X SJL/J).

Authors:  Subburaman Mohan; Godfred Masinde; Xinmin Li; David J Baylink
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

10.  Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.

Authors:  Margarethe Biong; Inger T Gram; Ilene Brill; Fredrik Johansen; Hiroko K Solvang; Grethe I G Alnaes; Toril Fagerheim; Yngve Bremnes; Stephen J Chanock; Laurie Burdett; Meredith Yeager; Giske Ursin; Vessela N Kristensen
Journal:  BMC Med Genomics       Date:  2010-03-19       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.